CD5 monoclonals/RIPs (Italfarmaco)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameCD5 monoclonals/RIPs (Italfarmaco)

Drug Alias Nametype-1 RIPs (Italfarmaco)Dianthin 30

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsAutoimmune DiseasesNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryItaly

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesItalfarmaco Spa

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesItalfarmaco Spa

Active IndicationsN/A

Inactive IndicationsAutoimmune DiseasesNeoplasms

Other Information

ATC CodeN/A